Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yas Daru is a prominent Iranian pharmaceutical company established in 1994, specializing in the production of high-quality generic medicines and herbal-based therapeutic products. The company operates from a GMP-certified manufacturing facility in Tehran, focusing on a wide range of therapeutic areas including gastroenterology, cardiology, and metabolic disorders. Yas Daru is particularly recognized for its integration of traditional herbal medicine with modern pharmaceutical technology, offering a diverse portfolio of both prescription and over-the-counter products. As a key player in the regional market, the company emphasizes research and development to expand its offerings in solid dosage forms and natural extracts. Their operations are supported by collaborations with leading academic institutions to ensure scientific rigor in their herbal formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yasdaru pharmaceuticals.